HK40077400B - Applying tumor treating fields (ttfields) via electrodes embedded into skull implants - Google Patents

Description

BACKGROUND

Tumor Treating Fields, or TTFields, are low intensity (e.g., 1-3 V/cm) alternating electric fields within the intermediate frequency range (e.g., 100-500 kHz) that inhibit cancer cell growth. This non-invasive treatment targets solid tumors and is described in US Patent 7,565,205 . 200 kHz TTFields are FDA approved for the treatment of glioblastoma (GBM), and may be delivered, for example, via the Optune^™ system. Optune^™ includes a field generator and two pairs of transducer arrays (i.e., electrode arrays) that are placed on the patient's shaved head. One pair of arrays is positioned to the left and right of the tumor, and the other pair of arrays is positioned anterior and posterior to the tumor.

Optimisation of the field distribution of TTFields is described in "Using computational phantoms to improve delivery of Tumor Treating Fields (TTFields) to patients" (2016, 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), doi:10.1109/EMBC.2016.7592208).

SUMMARY OF THE INVENTION

One aspect of the invention is directed to a skull implant according to claim 1.

Embodiments of the invention are disclosed in the dependent claims.

BRIEF DESCRIPTION OF THE DRAWINGS

• FIG. 1 depicts an embodiment that incorporates transducer arrays into four skull implants.
• FIG. 2 depicts a first embodiment for implementing any one of the skull implants depicted in FIG. 1.
• FIG. 3 depicts a second embodiment for implementing any one of the skull implants depicted in FIG. 1.
• FIG. 4 depicts a third embodiment for implementing any one of the skull implants depicted in FIG. 1.

Various embodiments are described in detail below with reference to the accompanying drawings, wherein like reference numerals represent like elements.

DESCRIPTION OF THE PREFERRED EMBODIMENTS

In a patient with glioblastoma, when the Optune^™ transducer arrays are positioned on a patient's shaved head, the electric field must pass through the patient's scalp and skull twice in order to reach the tumor. This situation introduces two problems. First, the presence of the skull between the transducer array and the tumor makes it more difficult to aim the field at the desired location (i.e., the tumor bed) in the brain. And second, due to attenuation of the electric field introduced by the skull and scalp, the voltage and current that is applied to the transducer arrays must be relatively high (e.g., on the order of 50 VAC and on the order of 1 A) in order to obtain an electric field with a therapeutically effective magnitude in the tumor bed.

FIG. 1 depicts an embodiment that ameliorates both these problems by incorporating transducer arrays into one or more skull implants. In the illustrated embodiment, skull implants 10L and 10R are positioned on the left and right sides of the patient's skull 15, respectively; and skull implants 10A and 10P are positioned on the anterior and posterior sides of the patient's skull 15, respectively. An AC field generator 11 (a) applies an AC voltage between the electrodes in skull implant 10A and the electrodes in skull implant 10P for a first interval of time (e.g., 1 second); then (b) applies an AC voltage between the electrodes in skull implant 10L and the electrodes in skull implant 10R for a second interval of time (e.g., 1 second); then repeats that two-step sequence (a) and (b) for the duration of the treatment.

FIG. 2 depicts a first embodiment for implementing any one of the skull implants 10A/P/L/R depicted in FIG. 1. In this embodiment, a rigid substrate 20 is shaped and dimensioned to replace a section of a skull. The substrate 20 has an inner side and an outer side, and may be formed using any of a variety of conventional approaches for forming a skull implant (including but not limited to 3D printing). In some preferred embodiments, the substrate 20 has an area of at least 5 cm².

An electrically conductive plate 22 is affixed to the inner side of the substrate 20. This plate 22 is preferably metal (e.g., copper, steel, etc.), but alternative conductive materials may also be used. The shape of the plate 22 may be customized to match the contours of the substrate 20, and the outer side of the plate 22 may be affixed to the substrate 20 using any of a variety of conventional approaches including but not limited to 3D printing and adhesives. A dielectric layer 24 is disposed on the inner side of the plate 22.

In many situations, it is preferable to capacitively coupled the electric field into the target region. The conductive plate 22 and the dielectric layer 24 form a capacitor, and using a higher capacitance improves the coupling of the electric field into the tumor. One approach for achieving a high capacitance is to use a ceramic dielectric material with a dielectric constant of at least 10,000 for implementing the dielectric layer 24, similar to the approach used in the conventional Optune^™ system. An alternative approach for increasing the capacitance is to use a flexible thin layer of high dielectric polymer as the dielectric layer 24.

Any portion of the conductive plate 22 that is not covered by the dielectric 24 should be covered by an appropriate insulator (e.g., medical grade silicone) to prevent non-capacitive coupling between the conductive plate 22 and tissue in the patient's head.

The inner end of an electrically conductive lead 26 (e.g., a wire) is disposed in electrical contact with the plate 22. The lead 26 passes through the substrate 20, and the outer end of the lead 26 is configured to accept an electrical signal from an external device (e.g., the field generator 11 depicted in FIG. 1). This may be accomplished, for example, by providing a terminal at the outer end of the lead 26.

Assume, for example, that four sets of the apparatus 10 depicted in FIG. 2 are positioned on all four sides of the patient's head, (i.e., left, right, anterior, and posterior, respectively), as depicted in FIG. 1. The field generator 11 generates an AC voltage on the wires that lead to implant 10A and 10P, then generates an AC voltage on the wires that lead to implants 10L and 10R (in a repeating and alternating sequence as described above). A corresponding AC current will travel through the wires 26 until it reaches the conductive plate 22 in each of the implants 10 A/B/L/R. Due to the presence of the dielectric layers 24, the desired electric field will be imposed in the tumor bed via capacitive coupling.

Preferably, at least one temperature sensor (e.g. a thermistor, not shown) is integrated into each implant 10 A/P/L/R to reduce the risk of overheating any portion of the patient's brain. In some embodiments, appropriate wiring (not shown) passes through the substrate 20 and is used to route the signal from the temperature sensor to the system's controller (which may be located, for example, in the field generator 11 shown in FIG. 1). In alternative embodiments, the system may be configured to communicate with the temperature sensor wirelessly using any of a variety of conventional approaches.

FIG. 3 is similar to the FIG. 2 embodiment, except that instead of using a single conductive plate 22 and a single dielectric layer 24 (as in the FIG. 2 embodiment), a plurality of smaller conductive plates 32 and smaller dielectric layers 34 are used. Optionally, each of these smaller conductive plates 32 may be round. Optionally, each of the smaller dielectric layers 34 may be a ceramic coating disposed on the smaller conductive plate 32,

In the FIG. 3 embodiment, a single lead 36 passes through the substrate 20 to one of the conductive plates 32, and internal wiring 37 is used to route the current to the other conductive plates. Alternatively, as depicted in FIG. 4, the internal wiring may be omitted if each of the conductive plates 32 is provided with its own lead 36 that passes through the substrate 20.

Notably, since the electric field does not have to pass through the scalp or skull, the voltage and current used in this embodiment can be significantly lower than the voltage and current used in the conventional Optune^™ system for any given desired field strength at the tumor. (This is because in the conventional Optune^™ system, the electrodes are all positioned on the shaved scalp of the patient, which means that the electric field must traverse the scalp and skull twice to reach the tumor.)

In addition, when the transducer arrays are incorporated into skull implants, the planning of treatment so that the desired field appears in the tumor bed may be simplified because the electrical path between the transducer arrays on opposite sides of the tumor is simplified. Finally, incorporating transducer arrays into skull implants can improve treatment planning in situations where the position of a surgical wound or skin abnormalities might prevent the application of conventional Optune^™ transducer arrays to particular places on the surface of a patient's skin.

Note that FIG. 1 depicts that all of the electrodes are incorporated into respective skull implants 10A/P/L/R. But in alternative embodiments, only some sets of electrodes are incorporated into a skull implant, and the remaining sets of electrodes are positioned outside the patient's skull (as in conventional TTFields treatment using Optune^™). For example, one set of electrodes could be positioned in a skull implant 10A on the anterior side of the patient's head, and the sets of electrodes on the right, left, and posterior sides could all be positioned outside the patient's skull.

In other alternative embodiments, two or more sets of electrodes are incorporated into a single skull implant. For example, a single roughly hemispherical skull implant could be installed on a patient's head in place of the top hemisphere of the patient's skull, and all four sets of electrodes could be incorporated into that single skull implant (i.e., on the left, right, anterior, and posterior inner walls of the implant).

While the present invention has been disclosed with reference to certain embodiments, numerous modifications, alterations, and changes to the described embodiments are possible without departing from the scope of the present invention, as defined in the appended claims. Accordingly, it is intended that the present invention not be limited to the described embodiments, but that it has the full scope defined by the language of the following claims.

Claims (8)

1. A skull implant, comprising:

   a rigid substrate (20) shaped and dimensioned to replace a section of a skull, the substrate (20) having an inner side and an outer side;

   a plurality of electrically-conductive plates (32), each having an inner side and an outer side, wherein the outer side of each plate (32) is affixed to the inner side of the substrate (20);

   a dielectric layer (34) disposed on the inner side of each plate (32); and

   a first electrically-conductive lead (36) having an inner end and an outer end, wherein the inner end of the first lead (36) is disposed in electrical contact with a first one of the plates (32), and the first lead (36) passes through the substrate (20), with the outer end of the first lead (36) being configured to accept an electrical signal from an external device (11).
2. The skull implant of claim 1, further comprising: a temperature sensor positioned adjacent to the dielectric layer (34) on the first plate (32).
3. The skull implant of claim 2, further comprising: a wire that passes through the substrate (20) and terminates at the temperature sensor, wherein the wire is configured to transmit an electrical signal from the temperature sensor to the external device (11).
4. The skull implant of claim 3, wherein the temperature sensor comprises a thermistor.
5. The skull implant of claim 1, wherein the dielectric layer (34) comprises a ceramic layer with a dielectric constant of at least 10,000.
6. The skull implant of claim 1, wherein the dielectric layer (34) comprises a flexible, thin layer of high dielectric polymer.
7. The skull implant of claim 1, further comprising: a second electrically-conductive lead (36) having an inner end and an outer end, wherein the inner end of the second lead (36) is disposed in electrical contact with a second one of the plates (32), and the second lead (36) passes through the substrate (20), with the outer end of the second lead (36) being configured to accept an electrical signal from the external device (11).
8. The skull implant of claim 7, further comprising: an additional electrically-conductive lead (37) disposed to electrically connect the first one of the plates (32) with a second one of the plates (32).